Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response
- PMID: 26319792
- DOI: 10.1016/j.jmb.2015.08.016
Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response
Abstract
Studies of biopsies from infectious sites, explanted tissue and medical devises have provided evidence that biofilms are the underlying cause of a variety of tissue-associated and implant-associated recalcitrant human infections. With a need for novel anti-biofilm treatment strategies, research in biofilm infection microbiology, biofilm formation mechanisms and biofilm-associated antimicrobial tolerance has become an important area in microbiology. Substantial knowledge about biofilm formation mechanisms, biofilm-associated antimicrobial tolerance and immune evasion mechanisms has been obtained through work with biofilms grown in in vitro experimental setups, and the relevance of this information in the context of chronic infections is being investigated by the use of animal models of infection. Because our current in vitro experimental setups and animal models have limitations, new advanced in vitro models developed with knowledge about the chemical landscape at infectious sites are needed.
Keywords: Pseudomonas aeruginosa; antimicrobial tolerance; biofilm; structure.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
The role of bacterial biofilms in chronic infections.APMIS Suppl. 2013 May;(136):1-51. doi: 10.1111/apm.12099. APMIS Suppl. 2013. PMID: 23635385
-
Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.Expert Rev Mol Med. 2010 Apr 7;12:e11. doi: 10.1017/S1462399410001420. Expert Rev Mol Med. 2010. PMID: 20370936 Review.
-
Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.APMIS Suppl. 2014 Dec;(138):1-51. doi: 10.1111/apm.12335. APMIS Suppl. 2014. PMID: 25399808 Review.
-
Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.Future Microbiol. 2013 Jul;8(7):901-21. doi: 10.2217/fmb.13.57. Future Microbiol. 2013. PMID: 23841636 Review.
-
Pharmacokinetics and pharmacodynamics of antibiotics in biofilm infections of Pseudomonas aeruginosa in vitro and in vivo.Methods Mol Biol. 2014;1147:239-54. doi: 10.1007/978-1-4939-0467-9_17. Methods Mol Biol. 2014. PMID: 24664838
Cited by
-
Antimicrobial Silver Nanoparticles for Wound Healing Application: Progress and Future Trends.Materials (Basel). 2019 Aug 9;12(16):2540. doi: 10.3390/ma12162540. Materials (Basel). 2019. PMID: 31404974 Free PMC article. Review.
-
In vitro antibacterial and early stage biofilm inhibitory potential of an edible chitosan and its phenolic conjugates against Pseudomonas aeruginosa and Listeria monocytogenes.3 Biotech. 2018 Oct;8(10):439. doi: 10.1007/s13205-018-1451-4. Epub 2018 Oct 4. 3 Biotech. 2018. PMID: 30306008 Free PMC article.
-
PutA Is Required for Virulence and Regulated by PruR in Pseudomonas aeruginosa.Front Microbiol. 2018 Mar 26;9:548. doi: 10.3389/fmicb.2018.00548. eCollection 2018. Front Microbiol. 2018. PMID: 29632523 Free PMC article.
-
Tryptophan interferes with the quorum sensing and cell surface hydrophobicity of Staphylococcus aureus: a promising approach to inhibit the biofilm development.3 Biotech. 2021 Aug;11(8):376. doi: 10.1007/s13205-021-02924-3. Epub 2021 Jul 21. 3 Biotech. 2021. PMID: 34367868 Free PMC article.
-
Potential biofilm control strategies for extended spaceflight missions.Biofilm. 2020 May 30;2:100026. doi: 10.1016/j.bioflm.2020.100026. eCollection 2020 Dec. Biofilm. 2020. PMID: 33447811 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical